Rewriting the Rules: How AMPS Is Disrupting the PBM Model with Purpose 

May 6, 2025

Anthony Masotto, Executive Vice President, GM Drexi 

The pharmacy benefit management industry has operated behind a curtain for far too long. Spread pricing, hidden rebates, and complex contracts have become the norm, leaving organizations with little visibility and even less trust in the process. 

At AMPS, we believe that model is broken. So, we built something better. 

Drexi is the pharmacy benefit solution of AMPS, created for organizations that are ready to walk away from outdated PBM practices and toward a smarter, simpler way to manage pharmacy benefits. 

In a recent feature in Top Doctor Magazine, I had the opportunity to share how Drexi is helping labor unions, brokers, and benefit leaders take back control of their pharmacy spend. These organizations are stepping forward and demanding better for their members. Drexi is helping them deliver on that promise. 

We are not here to improve the traditional PBM experience. We are here to replace it. 

Drexi offers full visibility into pharmacy pricing. There are no hidden fees, no rebate games, and no complex terms. Savings go directly to the plan, and members receive the medications they need through a process that is built to be clear and dependable. 

This is what it means to be unapologetically disruptive. 

We are not afraid to challenge the system. We are focused on building one that works. With Drexi, AMPS delivers a pharmacy benefit experience that puts people first and protects the financial health of the organizations we serve. 

This feature in Top Doctor Magazine reinforces what we stand for, and we will keep building better and fighting for the organizations who believe their members deserve more. 

If you are exploring new solutions for pharmacy benefits, this article is a great place to begin. 

Read the full feature in Top Doctor Magazine: Special Issue - Bobby Bartels and Dr. Robert Goldman - Top Doctor Magazine

News and Insights

AMPS Launches TruPrice: Smarter, More Accurate Claim Pricing Technology

READ MORE

Beyond the Buzzwords: Why Brokers Are Turning to PriceDynamix for Smarter, More Dynamic RBP

READ MORE

AMPS Response to the FDA’s May 21 Announcement on State Drug Importation Programs

READ MORE
Follow Us
© 2025 AMPS